PyInvesting

Market research

000153.SHE Anhui Fengyuan Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

4.75 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2B
P/E ratio
29.44
Analyst target
Not available
Dividend yield
1.9%
Beta
0.43

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Anhui Fengyuan Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.

From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.

Anhui Fengyuan Pharmaceutical Co., Ltd's total revenue rose by 3.8% to $849M since the same quarter in the previous year.

Its net income has dropped by 30.6% to $13M since the same quarter in the previous year.

Finally, its free cash flow fell by 791.8% to $-21M since the same quarter in the previous year.

Based on the above factors, Anhui Fengyuan Pharmaceutical Co., Ltd gets an overall score of 3/5.